In the present study we tested the hypothesis that nitric oxide may pl
ay a role in the pathogenesis of multiple organ failure induced by per
itoneal injection of zymosan in the rat. A severe inflammatory respons
e characterized by peritoneal exudation, high plasma and peritoneal le
vels of nitrate/nitrite (breakdown products of nitric oxide), prostagl
andin E-2 and leukocyte infiltration into peritoneal exudate was induc
ed by zymosan administration. This inflammatory process started within
3 h of administration and onset occurred at 18 h, coinciding with dam
age of lung, small intestine and liver, as assessed by histological ex
amination and by increase of myeloperoxidase activity, indicative of n
eutrophil infiltration. Furthermore, at 18 h after zymosan-induced per
itonitis, expression of inducible nitric oxide synthase enzyme was fou
nd mainly in the macrophages of inflamed lungs. Subcutaneously adminis
tration of a nonisoform selective nitric oxide synthase inhibitor, N-G
-nitro-L-arginine methyl ester, reduced formation of peritoneal exudat
e fluid, blocked plasma and peritoneal nitrate/nitrite accumulation, a
nd attenuated the elevated release of peritoneal prostaglandin E-2. In
addition, nitric oxide synthase inhibition was effective in preventin
g the development of organ failure since tissue injury and neutrophil
infiltration, by myeloperoxidase evaluation, was reduced in lung, smal
l intestine, and liver. In conclusion, major findings of our study are
that nitric oxide exerts a proinflammatory role in the development of
multiple organ failure and nitric oxide synthase inhibition is an eff
ective antiinflammatory therapeutic tool, since inhibits not only nitr
ic oxide but also prostaglandin production and cellular infiltration i
n inflamed organs.